Looking to boost your patients’ rosacea treatment results? If you’re just prescribing a topical, like Rhofade^® cream, it might be time to consider adding the Vbeam^® pulsed dye laser (PDL) to enhance your results. A study published in “Lasers in Surgery and Medicine” showed the combined effect of treatment with PDL and daily oxymetazoline 1% cream (Rhofade) can successfully reduce erythema and telangiectasias, when compared to the cream alone.¹

Take your topical rosacea treatments to the next level with Vbeam PDL technology.

Read the peer-reviewed study now!
Submit the form and we’ll send a copy to your inbox, along with a clinical summary download.

Have questions about Vbeam technology or ready to take the next step? Click here to get a call back from a member of our sales team.

1. Sodha P, Suggs A, Munavalli GS, Friedman PM. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea. Lasers Surg Med. 2021 Jul 7.

Vbeam is a registered trademark of Candela. Rhofade is a registered trademark of EPI Health, LLC.